Apollo Endosurgery, Inc. / Fundamentals
Income statement
- Net revenue
€66.22M - Cost of goods sold
€29.66M - Gross profit
€36.55M - SG&A expenses
€48.76M - R&D expenses
€10.26M - EBITDA
-€24.47M - D&A
-€3.27M - EBIT
-€23.97M - Interest expenses
€4.02M - EBT
-€33.82M - Tax expenses
€503.14K - Net income
-€34.32M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€4.97M - Changes in working capital
-€5.98M - Operating cash flow
-€26.93M - Capex
€2.36M - Other investing cash flow
-€72.37K - Net investing cash flow
-€2.36M - Total cash dividends paid
€0.00 - Issuance of common stock
€1.58M - Debt repayment
€0.00 - Other financing cash flow
€300.68K - Net financing cash flow
€300.68K - Foreign exchange effects
-€122.34K - Net change in cash
-€29.12M - Cash at end of period
€49.98M - Free cash flow
-€24.57M
Balance sheet
- Cash and cash equivalents
€49.11M - Cash and short-term investments
€49.11M - Total receivables
€12.92M - Inventory
€15.72M - Other current assets
€2.27M - Total current assets
€80.02M - Property, plant & equipment
€6.47M - Goodwill
€4.56M - Intangible assets
€2.69M - Long-term investments
€0.00 - Other non-current assets
€1.24M - Total non-current assets
€14.95M - Total assets
€94.97M - Accounts payable
€6.39M - Short-term debt
€17.45M - Other current liabilities
€9.46M - Total current liabilities
€34.06M - Long-term debt
€31.71M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€1.11M - Total non-current liabilities
€32.83M - Total liabilities
€66.89M - Common stock
€36.19K - Retained earnings
-€290.60M - Other equity
€4.29M - Total equity
€28.08M - Total liabilities and shareholders' equity
€94.97M
Company information
- Market capitalization
€494.47M - Employees
202 - Enterprise Value
€579.78M
Company ratios
- Gross margin
-
55.2% Much worse than peer group: 21,859.0% - EBITDA margin
-
-37.0% Much worse than peer group: 41,756.8% - EBIT margin
-
-36.2% Much worse than peer group: 29,911.0% - EBT margin
-
-51.1% Much worse than peer group: 35,087.9% - Net margin
-
-51.8% Much better than peer group: -57,182.7% - ROE
-
-122.2% Much worse than peer group: -39.0% - ROA
-
-36.1% Better than peer group: -43.4% - Asset turnover
-
69.7% Much better than peer group: 31.0% - FCF margin
-
-44.2% Much worse than peer group: 28,652.1% - FCF yield
-5.9% - Efficiency ratio
137.0% - Net sales per employee
-
€327.80K - Net income per employee
-
-€169.92K